Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics), Application (Therapeutic, Diagnostics), Disease (Cancer, Gastrointestinal, Infectious), Type (Peptide, Live Biotherapeutic Product, FMT) - Global Forecast to 2029
The human microbiome market is projected to reach $1,370 million by 2029. Human microbiome research spending market report provides crucial industry insights that will help your business grow.
This market research study involves extensive use of secondary sources, directories, & databases to identify & collect information useful for this technical, market-oriented, & financial study of the global human microbiome market.
The human microbiome market's size was estimated through various secondary research approaches and triangulated with inputs from primary research.
The human microbiome market's size was estimated through various secondary research approaches and triangulated with inputs from primary research.
The human microbiome market is projected to reach USD 1,598 million by 2028 from USD 894 million in 2025.
This market research study involves the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study.
After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and subsegments.
This market research study involves the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study.
This market research study involves the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study.
This market research study involves the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study.
After arriving at the overall market size—using the market size estimation processes explained above—the market was split into several segments and subsegments.
Enterome Bioscience (France) and Seres Therapeutics (US) are the Key Players in the Human Microbiome Market
The human microbiome market is projected to reach USD 1,598 million by 2028 from USD 894 million in 2025, at a CAGR of 21.3% from 2025 to 2028.
This market research study involves the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study.
This market research study involves the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study.
Enterome Bioscience (France) and Seres Therapeutics (US) are one of the Key Players in the Human Microbiome Market
The human microbiome market is projected to reach USD 1,598 million by 2028 from USD 894 million in 2025, at a CAGR of 21.3% from 2025 to 2028.
The human microbiome market is projected to reach USD 1,598 million by 2028 from USD 894 million in 2025, at a CAGR of 21.3% from 2025 to 2028.
The human microbiome market is projected to reach USD 1,598 million by 2028 from USD 894 million in 2025, at a CAGR of 21.3% from 2025 to 2028.
Various growth strategies have been adopted by these players, such as agreements, collaborations, partnerships, and acquisitions to increase their presence in the global human microbiome market.
The human microbiome market is projected to reach USD 1,598 million by 2028 from USD 894 million in 2025, at a CAGR of 21.3% from 2025 to 2028.
The human microbiome market is projected to reach USD 1,598 million by 2028 from USD 894 million in 2025, at a CAGR of 21.3% from 2025 to 2028.
The human microbiome market is projected to reach USD 1,598 million by 2028 from USD 894 million in 2025, at a CAGR of 21.3% from 2025 to 2028.t
The major players in the human microbiome market include Enterome Bioscience (France), 4D Pharma (UK), and Seres Therapeutics (US).
The global human microbiome market is projected to reach USD 1,731 million in 2027 from USD 942 million in 2024, at CAGR of 22.5 % during the forecast period.
The global human microbiome market is projected to reach USD 1,731 million in 2027 from USD 942 million in 2024, at CAGR of 22.5% during the forecast period.
The global human microbiome market is projected to reach USD 1,731 million in 2027 from USD 942 million in 2024, at CAGR of 22.5 % during the forecast period.
Enterome Bioscience (France) and Seres Therapeutics (US) are on of the leading players in the human microbiome market
This market is expected to grow from USD 942 million in 2024 to USD 1,731 million by 2027, at a CAGR of 22.5 % during the forecast period.
Enterome Bioscience (France) and Seres Therapeutics (US) are one t=of the Leading Players in the global Human Microbiome Industry.
This market is expected to grow from USD 942 million in 2024 to USD 1,731 million by 2027, at a CAGR of 22.5 % during the forecast period.
This market is expected to grow from USD 942 million in 2024 to USD 1,731 million by 2027, at a CAGR of 22.5 % during the forecast period.
This market is expected to grow from USD 942 million in 2024 to USD 1,731 million by 2027, at a CAGR of 22.5 % during the forecast period.
This market is expected to grow from USD 942 million in 2024 to USD 1,731 million by 2027, at a CAGR of 22.5 % during the forecast period.
This market is expected to grow from USD 942 million in 2024 to USD 1,731 million by 2027, at a CAGR of 22.5 % during the forecast period.
Microbiomes are responsible for a wide variety of metabolic and developmental processes—from food digestion to vitamin synthesis and even brain function.
Market growth is largely driven by the increasing focus on the development of human microbiome therapy. It has also become a validated target for drug development.
Microbiomes are responsible for a wide variety of metabolic and developmental processes—from food digestion to vitamin synthesis and even brain function.
This market is expected to grow from USD 942 million in 2024 to USD 1,731 million by 2027, at a CAGR of 22.5 % during the forecast period.
This report is expected to grow from USD 942 million in 2024 to USD 1,731 million by 2027, at a CAGR of 22.5 % during the forecast period.
The Human Microbiome Market is projected to reach USD 899 million by 2025 from USD 506 million in 2022, at a CAGR of 21.1% from 2022 to 2025.
This report analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the World.
The global human microbiome market is estimated to reach USD 899.1 Million by 2025, growing at a CAGR of 21.1% during the forecast period (2022–2025).
This report analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the World.
The human microbiome market is expected to reach USD 899.1 Million by 2025 from USD 506.5 Million in 2022 growing at a CAGR of 21.1% during the forecast period (2022–2025).
The human microbiome market is expected to reach USD 899.1 Million by 2025 from USD 506.5 Million in 2022 growing at a CAGR of 21.1% during the forecast period (2022–2025).
The human microbiome market is expected to reach USD 899.1 Million by 2025 from USD 506.5 Million in 2022 growing at a CAGR of 21.1% during the forecast period (2022–2025).
This report analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the World.
The human microbiome market is expected to reach USD 899.1 Million by 2025 from USD 506.5 Million in 2022 growing at a CAGR of 21.1% during the forecast period (2022–2025).